Overview
Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
Status:
Unknown status
Unknown status
Trial end date:
2013-12-01
2013-12-01
Target enrollment:
Participant gender: